Kouichi Tamura

Executive Officer in charge, Research & Head of Kobe Research Institutes at Healios

Kouichi Tamura led all Transplantation research projects at Fujisawa Pharmaceutical Co., Ltd. (currently Astellas Pharma Inc.), and played a core role to develop Tacrolimus, a cornerstone Immunosuppressant. After the merger to become Astellas, he served as a Senior Vice President and Director of Astellas Research Institute of America, and developed the Drug Discovery Research on Immunology, Inflammatory and Central Nervous System.

He became a Corporate Officer and Head of the Kobe Research Institute at Healios in 2014.